TMC
AMPE

Trellus Management Company’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Trellus Management Company’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-267
Closed -$103K – 80
2016
Q2 		$103K Hold
267
– – 0.17% 57
2016
Q1 		$180K Sell
267
-133
-33% -$89.6K 0.31% 57
2015
Q4 		$420K Buy
400
+133
+50% +$132K 0.62% 52
2015
Q3 		$231K Hold
267
– – 0.34% 68
2015
Q2 		$190K Buy
+267
New +$284K 0.21% 87

Other funds holding AMPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Trellus Management Company's AMPE Position: Q2 2018 in Review

Trellus Management Company sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2018, closing a stake of 48 shares — an estimated $49K sold.

Trellus Management Company first reported a position in AMPE in Q1 2014 and held it in 10 quarters. The position peaked at $1.04M in Q2 2014. 86 funds tracked by Wall St. Rank hold AMPE as of Q2 2018.

  • Trellus Management Company reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Trellus Management Company sold 48 Ampio Pharmaceuticals Inc. shares in Q2 2018, an estimated $49K.
  • Trellus Management Company first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 10 quarters.
  • Trellus Management Company's Ampio Pharmaceuticals Inc. position peaked at $1.04M in Q2 2014.
  • 86 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2018.

Based on Trellus Management Company's 13F filing for Q2 2018, filed 25 Jul 2018.